Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Soligenix, Inc. - Product Pipeline Review 2016 - Research and Markets

Research and Markets
Posted on: 18 Nov 16

Research and Markets has announced the addition of the "Soligenix, Inc. - Product Pipeline Review - 2016" company profile to their offering.

This report provides comprehensive information on the therapeutic development for Soligenix, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Soligenix and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Reasons to Buy:

  • Evaluate Soligenix, Inc.'s strategic position with total access to detailed information on its product pipeline.
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Identify and understand important and diverse types of therapeutics under development for Soligenix, Inc.
  • Identify potential new clients or partners in the target demographic.
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics.
  • Devise corrective measures for pipeline projects by understanding Soligenix, Inc.'s pipeline depth and focus of pipeline therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Key Topics Covered:

  1. Introduction
  2. Soligenix Overview
  3. Therapeutics Development
  4. Pipeline Products for Soligenix - Overview
  5. Pipeline Products for Soligenix - Comparative Analysis
  6. Soligenix - Therapeutics under Development by Companies
  7. Soligenix - Therapeutics under Investigation by Universities/Institutes
  8. Soligenix - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Soligenix - Products under Development by Companies
  13. Soligenix - Products under Investigation by Universities/Institutes
  14. Soligenix - Companies Involved in Therapeutics Development

For more information about this company profile visit

View source version on

Business Wire

Last updated on: 18/11/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.